Connect with us
DAPA Banner

Business

New water regulator plans for Wales

Published

on

Business Live

A new regulator to replace Ofwat in Wales would require UK Government approval

(Image: PA)

The Welsh Government has published major long-term plans for stronger regulation of the water industry. The plans would mean setting up a new dedicated Welsh economic regulator for water in Wales, which would replace Ofwat.

Advertisement

It would require legislation and an updated framework designed to encourage investment, protect the environment, and deliver a water system that works for Wales.

It comes after a catalogue of sewage scandals and mounting public anger over water companies’ performance led to a major review which called for oversight of the industry in Wales and England to be completely overhauled.

The government consultation document makes clear that for its plans to happen it would need the UK Government to agree to devolve further powers to Wales – something which the current administration has come under fire for refusing in other areas such as justice.

READ MORE: More business rate relief for hospitality firms in WalesREAD MORE: It’s wrong to caricature Welsh firms as being too cautious when it comes to growth finance

Advertisement

There needs, it says, to be “hard decisions”, including investment and changes to infrastructure which will “exceed what customers can reasonably afford”.

The long-term strategy to deliver the plans forecasts legislative change would happen between 2026 and 2028-29.

There would then be a new Welsh economic regulator and system planning function for water from 2028 until the early 2030s with an economic regulator for water set up and operating from the mid 2030s onwards.

The 88-page paper says despite investment improvements need to happen.

Advertisement

“Wales now faces a new reality. Climate and nature emergencies, alongside persistent challenges, demand urgent action,” says the report.

“The water system designed for a different time no longer meets the needs of our people, our environment, or our economy.

“We have made good progress but people across Wales are rightly concerned about sewage discharges, outdated infrastructure, and the condition of water in their communities. We cannot stand still. It is time for fundamental reset.

“Improving the health of our rivers will require action across the whole water environment.

Advertisement

“Pressures from land use, agriculture, and the way organic materials are managed once applied to land all contribute to the condition of our catchments.

“We are therefore taking a whole-system approach, ensuring work to change water governance in Wales is aligned with wider action to address nutrient pollution, strengthen accountability, and restore trust that the system works in the public interest.”

The report says the following measure need to happen:

  • A separate regulator for Wales. This would “strengthen public confidence and support long-term investment in infrastructure and environmental protection”;
  • a clear, long-term strategic direction that articulates national priorities, sets interim targets, and provides a framework for delivery across sectors;
  • a change from a “fragmented and process-heavy planning towards a coherent, outcome-focused system”;
  • a longer-term integrated plan covering water resources and water supply, drainage and wastewater, and environmental water quality to inform investment priorities and to provide clarity to the wider system, for example land use planning; and
  • working with the water industry to reduce inappropriate materials entering their network such as wipes, sanitary products, cotton buds, fats, oils, and greases by preventing these items from being flushed or poured away. Reducing this burden on water systems protects the environment, lowers maintenance costs, and strengthens resilience, helping communities enjoy cleaner, safer, and more reliable water while supporting more stable and potentially lower bills.

The report says any reforming governance, enforcement and monitoring in Wales will be a “complex and interdependent process”.

“It will begin with a comprehensive review of existing frameworks to identify gaps, overlaps, and areas of weakness. This will be followed by engagement across government, regulators, industry and civil society to design a system that reflects Welsh values and priorities.

Advertisement

“Throughout effective engagement with the UK Government will be essential, particularly during the period when regulation of Welsh water companies continues through the new UK Government water regulator, until the Welsh regulator is established.

“The process will then move forward through legislative and operational change, coordinated with the establishment of the new Welsh regulator, with regulation of Welsh water companies continuing through the new English regulator until the Welsh regulator is in place,” it says.

It however says that changes could lead to “confusion, resistance, or unintended consequences” and the reforms could be seen as “punitive or overly centralised”.

Afonydd Cymru, which represents river trusts in Wales, told the BBC the proposals provided “a beacon of hope” but urged the government to act quickly.

Advertisement

Chief executive Gail Davies-Walsh said: “It must be remembered that it is just a consultation at this stage and nothing yet is set in stone”.

She added that the “thorny question of funding was not resolved either”.

Interim chief executive of water regulator Ofwat Chris Walters said: “This Green Paper sets the framework for the future of the water sector in Wales, which we welcome. The creation of a dedicated regulator for Wales will strengthen scrutiny and accountability within a framework designed specifically for Wales, marking an important evolution in how companies will be overseen going forward.

“As the Welsh Government develops the regulatory new body, we remain committed to the delivery of our core functions and are already working closely with Welsh Government, Defra, Natural Resources Wales and other regulators to ensure that the sector moves towards a more integrated and resilient future.

Advertisement

“Our 2024 Price Review approved record investment in Wales- more than £6.3bn- which will enable major improvements for customers and the environment by 2030.”

Derek Walker, Future Generations Commissioner for Wales, said: “This needs to be a wake-up for the water industry and is an overdue opportunity to fix the problems of the past and become a clean water abundant nation. Welsh Government has acted decisively, and we now need to make sure that securing healthy waters for Wales is a priority for the UK Government and the next Welsh Government.

“Everything must be done to ensure the transition to a new body happens without delay to deliver long-term environmental recovery and affordability, alongside strengthened compliance and regulation.

“Any investment in the water system must work urgently to restore nature, support food production, improve climate resilience and deliver new housing and infrastructure as we protect the long-term health of our rivers, seas and the water that’s essential to life.”

Advertisement

Deputy first minister Huw Irranca-Davies said: “Our ambition is clear and bold: clean and thriving rivers, safe and high-quality drinking water, fair and affordable services, and modern infrastructure ready for the future. We will strengthen accountability, rebuild trust, and create a system that is simpler, stronger and more transparent.

“Wales now faces an urgent reality. Climate and nature emergencies, ageing infrastructure, and public concerns about water quality demand decisive action. The system we have today was designed for a different era. It is time for a fundamental reset.”

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Fuel security level unchanged despite blaze at refinery

Published

on

Fuel security level unchanged despite blaze at refinery

Australia won’t increase its fuel-security measures despite a fire wiping out nearly half of petrol production at one of the country’s only refineries, the prime minister says.

Continue Reading

Business

Fuchs SE (FUPBY) Analyst/Investor Day – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Fuchs SE (FUPBY) Analyst/Investor Day – Slideshow

Continue Reading

Business

Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC Life

Published

on

Stocks in news: Wipro, HUL, Angel One, Alembic Pharma, HDFC Life
Markets witnessed a volatile session on Thursday, eventually ending on a flat note as the index took a breather after the recent rebound. Analysts reiterate positive stance on the Nifty and recommend a buy on dips approach, focusing on stock selection based on rotational sectoral trends.

In today’s trade, shares of Wipro, HUL, Angel One, Alembic Pharma, HDFC Life among others will be in focus due to various news developments and fourth quarter results.

Angel One

Angel One reported a sharp rise in profit for the March quarter, driven by strong client activity and operating leverage. Profit after tax stood at Rs 320 crore in the fourth quarter, marking an 84% year-on-year (YoY) increase, while rising 19% sequentially. The strong profit growth was supported by higher trading volumes and better monetisation across segments.Wipro

IT services major Wipro reported 2% fall in its consolidated net profit at Rs 3502 crore in the fourth quarter. The company’s board has also approved a buyback of Rs 15,000 crore, along with its financial results. Revenue from operations, meanwhile, increased 8% YoY to Rs 24,236 crore.


HDFC Life

HDFC Life Insurance said it will issue shares worth Rs 1,000 crore to promoter HDFC Bank on a preferential basis, even as the insurer reported a modest rise in March quarter profit. The company will allot 1.45 crore equity shares at Rs 688.52 apiece to HDFC Bank, subject to shareholder and regulatory approvals. The capital raise aims to strengthen solvency and support future growth.
HUL
Hindustan Unilever Limited has hiked prices across its soap portfolio, passing on rising raw material and packaging costs to consumers, The Times of India reported, with increases ranging between Rs 1 and Rs 20. For FMCG companies that were counting on GST cuts to revive consumption after a prolonged slowdown, the current situation may push back a demand recovery just as early signs of improvement had begun to reflect in recent quarterly earnings.

Alembic Pharma

Alembic Pharmaceuticals Ltd on Thursday said it has received final approval from the US health regulator for its generic version of methotrexate injection used in treatment of different types of cancers and arthritis.

Advertisement
Continue Reading

Business

Gelsinger Patrick P, Gloo Holdings director, buys $264k in shares

Published

on


Gelsinger Patrick P, Gloo Holdings director, buys $264k in shares

Continue Reading

Business

Bloomberg Exec Accused of Turning Internal Chat Into Sexual Harassment Channel

Published

on

Bloomberg Exec Accused of Turning Internal Chat Into Sexual Harassment

A senior manager at Bloomberg LP is facing serious allegations after a lawsuit claimed the company’s internal chat system was used to send explicit and unwanted messages to an employee.

The case, filed in New York Supreme Court on April 13, accuses the company of failing to act on repeated complaints.

The lawsuit was brought by Charles Kyle O’Rourke, an account manager who has worked at Bloomberg since 2019.

He claims senior manager Peter Elliot sent him inappropriate sexual messages during work conversations, creating what the complaint describes as a hostile work environment.

Advertisement

According to the filing, the messages were sent in February 2025 while O’Rourke was discussing travel plans.

The complaint alleges Elliot made crude comments involving sex acts and personal behavior that were not welcome.

One message reportedly included explicit language about travel and sexual activity, which O’Rourke says crossed professional boundaries.

“Over the course of his nearly six-year tenure, Mr. O’Rourke has been subjected to repeated acts of sexual harassment,” the complaint states, adding that the situation worsened due to what it describes as a lack of support from management, NY Post reported.

Advertisement

O’Rourke says he reported the messages to senior leaders, but no action was taken. The lawsuit claims the harassment continued despite his complaints, placing responsibility on the company for not stepping in.

Bloomberg Lawsuit Alleges Retaliation

The filing also includes claims of retaliation. O’Rourke alleges that after he raised concerns and asked for workplace accommodations related to ADHD and anxiety, his direct manager, David LaPaglia, began treating him unfairly.

The complaint says LaPaglia micromanaged his work, reduced his client responsibilities, and told clients he was no longer with the company.

According to NationalToday , as a result of the situation, O’Rourke took a medical leave of absence on August 19, which the lawsuit describes as a response to pressure that pushed him toward leaving his job.

Advertisement

The case brings several legal claims against Bloomberg under New York State and City laws.

These include allegations of a hostile work environment, sex discrimination, disability discrimination, and retaliation.

The lawsuit also argues that Bloomberg is responsible for the actions of its managers because of their leadership roles.

O’Rourke is seeking damages and is asking the court to require changes to Bloomberg’s internal policies, including stronger harassment reporting systems and better employee protections.

Advertisement

In response, a spokesperson for Bloomberg said the company has reviewed the claims and believes they have no merit.

Originally published on vcpost.com

Continue Reading

Business

Wall Street sets another record after US stocks tick higher

Published

on

Wall Street sets another record after US stocks tick higher

The US stock market ticked to another record high Thursday as Wall Street waits for more clues about what will happen in the Iran war before making its next big move.

Continue Reading

Business

Tariq Musa, Guardant Health director, sells $9840 in stock

Published

on


Tariq Musa, Guardant Health director, sells $9840 in stock

Continue Reading

Business

Bear costume scheme nets convictions in California insurance fraud case

Published

on

Bear costume scheme nets convictions in California insurance fraud case

Three Los Angeles-area residents were recently convicted in an unusual insurance fraud scheme using a person in a bear costume to fake attacks on high-end vehicles to collect insurance payouts.

As part of the California Department of Insurance’s Operation Bear Claw, Alfiya Zuckerman, 39, of Valley Village; Ruben Tamrazian, 26, of Glendale; and Vahe Muradkhanyan, 32, of Glendale, pleaded no contest to felony insurance fraud and were sentenced to 180 days in jail and two years of supervised probation and were ordered to pay restitution.

Advertisement

A fourth suspect, Ararat Chirkinian, 39, of Glendale, is scheduled to return to court in September for a preliminary hearing.

The bear costume

The bear costume used in the alleged January insurance scam.  (California Department of Insurance / Fox News)

PERSON IN BEAR COSTUME ATTACKS LUXURY CARS IN INSURANCE SCAM, CALIFORNIA INSURERS SAY

The investigation began after an insurance company flagged a suspicious claim tied to a Jan. 28, 2024, incident in Lake Arrowhead. 

The suspects claimed a bear entered their 2010 Rolls-Royce Ghost and caused interior damage, submitting video footage as evidence.

Advertisement

Detectives later determined the “bear” in the video was a person wearing a bear costume and uncovered two additional fraudulent claims submitted to separate insurance companies involving the same date and location but tied to a 2015 Mercedes G63 AMG and a 2022 Mercedes E350.

Bear costume arrests

Ararat Chirkinian, left, Alfiya Zuckerman and Ruben Tamrazian were arrested in the alleged insurance fraud.  (California Department of Insurance / Fox News)

VISA REPORT HIGHLIGHTS EMERGING SCAMS TARGETING CONSUMERS AND TRAVELERS

A biologist from the California Department of Fish and Wildlife reviewed the video and concluded the animal shown was “clearly a human in a bear suit,” according to authorities.

Detectives executed a search warrant and recovered the costume from the suspects’ home.

Advertisement

Officials said the total loss to the insurance companies was $141,839, though the names of the businesses were not released.

Insurance papers

Investigators said the insurance fraud scheme involved more than $100,000. (iStock / iStock)

“What may have looked unbelievable turned out to be exactly that, and now those responsible are being held accountable,” Insurance Commissioner Ricardo Lara wrote in a statement Thursday. “My Department’s investigators uncovered the facts, exposed this scam and helped bring these defendants to justice.

GET FOX BUSINESS ON THE GO BY CLICKING HERE

“Insurance fraud is a serious crime that drives up costs for consumers, and no scheme is too outrageous for us to investigate.”

Advertisement
Continue Reading

Business

NFIB Small Business Survey: Optimism Drops To 11-Month Low

Published

on

NFIB Small Business Survey: Optimism Drops To 11-Month Low

Interior of a small coffee shop

Luis Alvarez/DigitalVision via Getty Images

By Jennifer Nash

Originally published on April 15, 2026

The NFIB Small Business Optimism Index fell 3.0 points to 95.8, dropping below the index’s historical average for the first time since April 2025. This was below

Advertisement
Continue Reading

Business

David Ferrera on Building What Works in Medical Devices

Published

on

David Ferrera on Building What Works in Medical Devices

David Ferrera is a medical device engineer, entrepreneur, and inventor with nearly 30 years of experience in neurovascular and interventional medicine.

Based in Lake Forest, California, he has built a career focused on turning clinical ideas into real products that improve patient care.

He began his career at Boston Scientific before moving into more specialised roles in vascular and neurovascular technology. Over time, he co-founded and led several companies, including Micrus Endovascular, MindFrame, and Blockade Medical. Each company focused on solving specific problems in stroke treatment and interventional procedures. These ventures were later acquired by major industry players such as Johnson & Johnson, Terumo, Covidien, and Balt.

Ferrera is now CEO of RC Medical, a venture studio that partners with physicians to develop and commercialise new medical devices. He is also CEO and Chairman of Sonorous Neuro. His work centres on building structured, milestone-driven companies that address real clinical needs.

He holds more than 80 U.S. and international patents and is the author of Innovation in Translation, published by Advantage-Forbes. His approach is grounded in discipline, clear problem definition, and practical execution.

Advertisement

Beyond his professional work, Ferrera has been active in philanthropy, serving as Chair of the American Heart Association’s Orange County Heart & Stroke Ball. His career reflects a consistent focus on building solutions that move from concept to clinical use.

David Ferrera on Building What Actually Works in MedTech

Q: How did your career in medical devices begin?

I started at Boston Scientific in the early 1990s. I had a background in plastics engineering, so I was drawn to how materials and design could solve medical problems. Early on, I realised that the field moves quickly, but only when products actually work in real procedures.

Q: What was your first major step into leadership?

Co-founding Micrus Endovascular was a turning point. We were focused on neurovascular devices. At that time, the space was still developing. We had to build technology while also proving clinical value. That company was later acquired by Johnson & Johnson, which gave me a clear view of how larger organisations evaluate products.

Q: What did you learn from your time at MindFrame?

At MindFrame, I led product development and clinical research. We worked on one of the early mechanical thrombectomy systems for stroke. I remember watching cases where time was critical. Every delay mattered. That shaped how I think about design. A device is not just about function. It is about workflow.

Advertisement

Q: You have been part of several acquisitions. How did that shape your approach?

Each acquisition reinforced the same lesson. You need structure from the start. Regulatory planning, manufacturing, and clinical data cannot be afterthoughts. If those pieces are not aligned early, the company struggles later.

Q: Why did you decide to build RC Medical as a venture studio?

After building individual companies, I wanted a more repeatable model. At RC Medical, we partner with physicians who see problems every day. We validate early. We build in stages. We keep teams lean. It allows us to work on multiple ideas while maintaining discipline.

Q: How do physician partnerships influence your work?

They are essential. Physicians understand where procedures break down. One doctor once showed me a case where a device required multiple exchanges. It added several minutes. That insight led to a redesign focused on reducing steps. That is where real innovation comes from.

Q: What role does Sonorous Neuro play in your current work?

Sonorous Neuro is one of the companies formed through this model. I serve as CEO and Chairman. The focus is neurovascular care. We are working on improving how procedures are performed, especially in stroke intervention. It is about precision and efficiency.

Advertisement

Q: What challenges have you seen in recent years?

Regulatory expectations have increased. Capital is more selective. You cannot rely on momentum alone. You need clear milestones and strong data. That has made discipline even more important.

Q: How do you stay close to what matters in the field?

I spend time with physicians. I review clinical data. I focus on what is happening in procedure rooms, not just what is being presented at conferences. Real feedback comes from real use.

Q: How has your leadership style changed over time?

Early on, I focused heavily on technical details. Over time, I shifted towards alignment. Clear goals. Clear accountability. Teams perform better when expectations are simple and direct.

Q: What advice would you give to someone entering this space?

Start with the problem, not the technology. Spend time understanding the clinical need. Then build with discipline. Big ideas are common. Turning them into products that work is the hard part.

Advertisement

Continue Reading

Trending

Copyright © 2025